Tag: cerebral protection

Claret Medical closes US$14.5 million in Series C financing to extend...

Claret Medical, developer of the Sentinel cerebral protection system, has closed on a Series C financing of US$14.5 million led by Lightstone Ventures, with participation...

Reduced stroke and mortality with cerebral protection use in TAVI patients

A new study published in the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions underscores the role of the Sentinel Cerebral Protection System (Claret...

Trial of third generation cerebral protection device to be initiated by...

Plans to initiate clinical trials for a new, advanced version of the TriGuard cerebral embolic protection device (Keystone Heart) have been announced.  According to the...

Innovative Cardiovascular Solutions raises US$5 million in Series B financing for...

Innovative Cardiovascular Solutions (ICS) has completed an oversubscribed Series B round of financing totalling US$5 million. The company is currently developing the EMBLOK Embolic Protection...

Sentinel becomes first cerebral protection device to receive FDA approval

Claret Medical has received regulatory clearance from the FDA for its Sentinel cerebral protection system, via de novo classification, meaning that the device can...

First European cases using Emblok cerebral protection take place in Italy

The first European clinical cases using the Emblok Embolic Protection System (Innovative Cardiovascular Solutions) in patients undergoing TAVI (transcatheter aortic valve implantation) procedures have...